191 related articles for article (PubMed ID: 25625609)
21. Immunotherapy with dendritic cells and cytokine-induced killer cells for hepatocellular carcinoma: A meta-analysis.
Cao J; Kong FH; Liu X; Wang XB
World J Gastroenterol; 2019 Jul; 25(27):3649-3663. PubMed ID: 31367163
[TBL] [Abstract][Full Text] [Related]
22. CD40ligand-expressing dendritic cells induce regression of hepatocellular carcinoma by activating innate and acquired immunity in vivo.
Gonzalez-Carmona MA; Lukacs-Kornek V; Timmerman A; Shabani S; Kornek M; Vogt A; Yildiz Y; Sievers E; Schmidt-Wolf IG; Caselmann WH; Sauerbruch T; Schmitz V
Hepatology; 2008 Jul; 48(1):157-68. PubMed ID: 18537185
[TBL] [Abstract][Full Text] [Related]
23. Enhanced antitumor effects by the coculture of allotumor RNA-pulsed dendritic cells with autologous cytokine-induced killer cells on hormone-refractory prostate cancer.
Pang J; Gao X; Liu X; Wang K; Zhang Y; Feng L; Zhan H
Cancer Invest; 2007; 25(7):527-34. PubMed ID: 17952744
[TBL] [Abstract][Full Text] [Related]
24. The Combined Antitumor Effects of
Zhang J; Wu N; Lian Z; Feng H; Jiang Q; Chen X; Gong J; Qiao Z
Technol Cancer Res Treat; 2017 Dec; 16(6):1083-1091. PubMed ID: 29332456
[TBL] [Abstract][Full Text] [Related]
25. Dendritic cells infected by Ad-sh-SOCS1 enhance cytokine-induced killer (CIK) cell immunotherapeutic efficacy in cervical cancer models.
Zheng Y; Hu B; Xie S; Chen X; Hu Y; Chen W; Li S; Hu B
Cytotherapy; 2017 May; 19(5):617-628. PubMed ID: 28215653
[TBL] [Abstract][Full Text] [Related]
26. Glypican-3-Specific CAR T Cells Coexpressing IL15 and IL21 Have Superior Expansion and Antitumor Activity against Hepatocellular Carcinoma.
Batra SA; Rathi P; Guo L; Courtney AN; Fleurence J; Balzeau J; Shaik RS; Nguyen TP; Wu MF; Bulsara S; Mamonkin M; Metelitsa LS; Heczey A
Cancer Immunol Res; 2020 Mar; 8(3):309-320. PubMed ID: 31953246
[TBL] [Abstract][Full Text] [Related]
27. hIL-15 gene-modified human natural killer cells (NKL-IL15) augments the anti-human hepatocellular carcinoma effect in vivo.
Jiang W; Zhang C; Tian Z; Zhang J
Immunobiology; 2014 Jul; 219(7):547-53. PubMed ID: 24721706
[TBL] [Abstract][Full Text] [Related]
28. Dendritic cells pulsed with Hsp70 and HBxAg induce specific antitumor immune responses in hepatitis B virus-associated hepatocellular carcinoma.
Wang H; Feng F; Wang XP; Wang RS; Wu Y; Zhu MG; Zhang H; Zhuang ZX
Mol Med Rep; 2016 Feb; 13(2):1077-82. PubMed ID: 26647961
[TBL] [Abstract][Full Text] [Related]
29. [Killing activity in DC and CIK co-culture against hepatocarcinoma cells].
Chen BA; Li M; Sun ZY; Li CP; Gao C; Sun YY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Jun; 14(3):543-6. PubMed ID: 16800939
[TBL] [Abstract][Full Text] [Related]
30. Anti-tumor efficacy of a hepatocellular carcinoma vaccine based on dendritic cells combined with tumor-derived autophagosomes in murine models.
Su S; Zhou H; Xue M; Liu JY; Ding L; Cao M; Zhou ZX; Hu HM; Wang LX
Asian Pac J Cancer Prev; 2013; 14(5):3109-16. PubMed ID: 23803088
[TBL] [Abstract][Full Text] [Related]
31. PiggyBac-engineered T cells expressing a glypican-3-specific chimeric antigen receptor show potent activities against hepatocellular carcinoma.
Wang P; Qin W; Liu T; Jiang D; Cui L; Liu X; Fang Y; Tang X; Jin H; Qian Q
Immunobiology; 2020 Jan; 225(1):151850. PubMed ID: 31522780
[TBL] [Abstract][Full Text] [Related]
32. Potential therapeutic value of dendritic cells loaded with NY‑ESO‑1 protein for the immunotherapy of advanced hepatocellular carcinoma.
Chen Y; Huang A; Gao M; Yan Y; Zhang W
Int J Mol Med; 2013 Dec; 32(6):1366-72. PubMed ID: 24085111
[TBL] [Abstract][Full Text] [Related]
33. Antitumor activities of human autologous cytokine-induced killer (CIK) cells against hepatocellular carcinoma cells in vitro and in vivo.
Wang FS; Liu MX; Zhang B; Shi M; Lei ZY; Sun WB; Du QY; Chen JM
World J Gastroenterol; 2002 Jun; 8(3):464-8. PubMed ID: 12046071
[TBL] [Abstract][Full Text] [Related]
34. Anti-tumor activity of dendritic cell-cytokine induced killer cells (DC-CIKs) sensitized to HER2 against HER-positive breast cancer cells.
Wen YY; Hu XS
Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173208
[TBL] [Abstract][Full Text] [Related]
35. IL-12 improves the anti-HCC efficacy of dendritic cells loaded with exosomes from overexpressing Rab27a tumor cells.
Li J; Lin W; Huang T; Chen M; Lin Q
Exp Cell Res; 2024 Jun; 439(1):114073. PubMed ID: 38704079
[TBL] [Abstract][Full Text] [Related]
36. Coculturing dendritic cells with zoledronate acid efficiently enhance the anti-tumor effects of cytokine-induced killer cells.
Su X; Zhang L; Jin L; Ye J; Guan Z; Chen R
J Clin Immunol; 2010 Sep; 30(5):766-74. PubMed ID: 20549316
[TBL] [Abstract][Full Text] [Related]
37. GPC3-IL7-CCL19-CAR-T primes immune microenvironment reconstitution for hepatocellular carcinoma therapy.
Lu LL; Xiao SX; Lin ZY; Bai JJ; Li W; Song ZQ; Zhou YH; Lu B; Wu WZ
Cell Biol Toxicol; 2023 Dec; 39(6):3101-3119. PubMed ID: 37853185
[TBL] [Abstract][Full Text] [Related]
38. Biological activity of cytotoxic dendritic cells cocultured with cytokine-induced killer cells and their effect on acute leukemia cells.
Cheng XY; Li JL
Genet Mol Res; 2015 Oct; 14(4):13208-14. PubMed ID: 26535634
[TBL] [Abstract][Full Text] [Related]
39. [Cytotoxicity induced by HBsAg gene modified-dendritic cells against hepatocellular carcinoma cell HepG2.2.15].
Yang JY; Ren J; Bai J; Liu DH; Fan L; Si XM; Teng ZH; Yang WT
Ai Zheng; 2004 Aug; 23(8):914-7. PubMed ID: 15301714
[TBL] [Abstract][Full Text] [Related]
40. [Immune response of HBsAg gene-modified dendritic cell-based vaccine in HepG2. 2. 15 hepatocellular carcinoma cells].
Yang JY; Liu WC; Cao DY; Si XM; Teng ZH
Zhonghua Zhong Liu Za Zhi; 2007 Oct; 29(10):728-32. PubMed ID: 18396682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]